) has been revised to $4.20 / share. This is an increase of 10.75% from the prior estimate of $3.79 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...
Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results